About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in California | 1,848 Studies

Clinical Trials Breast CancerCalifornia

Breast Cancer Clinical Trials in California

Find 1,848 clinical trials for breast cancer near California. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1241-1260 of 1,848 trials

Active not recruitingCapivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast CancerPhase III, double-blind, randomised study assessing the efficacy of capivasertib + fulvestrant vs placebo + fulvestrant for the treatment of patients with locally advanced…NCT04305496·Gilbert, Arizona and 214 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedPatient Controlled Tissue Expansion for Breast ReconstructionThis study is designed to compare the performance and safety of the AirXpander tissue expander to standard saline expanders in patients undergoing two-stage breast reconstruction…NCT01425268·Greenbrae, California and 16 others

CompletedCharacterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast CancerThe purpose of this study is to identify tumor cells in the bloodstream (Circulating Tumor Cells, CTC's) from patient's with locally advanced or metastatic (stage IV) breast…NCT01048918·Duarte, California

CompletedStudy to Evaluate Surgical Excision Margins in Malignant Breast Lumpectomies With the PEAK PlasmaBladeThe purpose of this research study is to find out more about distinguishing between cancerous and non-cancerous breast cancer cells at the edges of tumors.NCT00972010·La Jolla, California and 2 others

UnknownAdjunctive Efficacy Study Of The SoftScan® Optical Breast Imaging SystemThe primary study endpoint -SoftScan adjunctive accuracy- will be used to test the hypothesis that the adjunctive combination of the SoftScan with x-ray mammography provides…NCT00267449·La Jolla, California and 5 others

RecruitingA Study of LY4337713 in Participants With FAP-Positive Solid TumorsThis is a study of LY4337713 in participants with certain types of cancer that is advanced or has spread.NCT07213791·Newport Beach, California and 29 others

CompletedPlatinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of ResponseThe purpose of this research study is to : * Determine how effective cisplatin or carboplatin is in slowing the time it takes for ER negative (estrogen-receptor-negative), PR…NCT00483223·Birmingham, Alabama and 9 others

WithdrawnS0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT00217659·Los Angeles, California and 56 others

CompletedTreatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone LesionsPatients with bone metastases or bone lesions caused by breast cancer, multiple myeloma or prostate cancer will be treated with IV Zometa in a 15 minute infusion.NCT00029224·Stockton, California and 6 others

CompletedAnalysis of Surgery in Patients Presenting With Stage IV Breast CancerThe purpose of this study is to study patients presenting with stage IV breast cancer.NCT00941759·Birmingham, Alabama and 19 others

RecruitingA Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)This study looks to advance a novel and potent strategy to eliminate minimal residual disease (MRD) in triple negative breast cancer (TNBC) present even after multimodal…NCT04333706·Los Angeles, California and 2 others

CompletedBreast Cancer Lymphedema: Role of Insulin Resistance/FOXC2To better understand the mechanisms leading to lymphedema development in breast cancer survivors, and the implications for potential innovative approaches to the screening…NCT00383604·Stanford, California

CompletedA Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)This first-in-human, open-label, multicenter, Phase Ia/Ib, adaptive, multiple ascending-dose study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics…NCT02627274·Tucson, Arizona and 25 others

CompletedAcupuncture for Sleep Disruption in Cancer SurvivorsThe proposed study will recruit 60 women with breast cancer who finished undergoing treatment who complain of persistent insomnia problems that began with onset of their cancer…NCT01162018·Stanford, California

CompletedBrief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing ChemotherapyThis randomized phase II trial studies how well brief behavioral therapy works in improving sleep disorders in patients with stage I-III breast cancer undergoing chemotherapy.NCT02002533·Stanford, California and 5 others

TerminatedA Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)This study will evaluate the efficacy, safety and patient-reported outcomes of trastuzumab emtansine plus atezolizumab compared with trastuzumab emtansine plus placebo in…NCT04740918·Redlands, California and 50 others

CompletedBevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By SurgeryRATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some find tumor cells and kill them or carry tumor-killing substances to them.NCT00305825·San Francisco, California and 1 other

CompletedPalbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast CancerThis research study is evaluating a drug called Palbociclib in combination with endocrine therapy as a possible treatment for hormone receptor positive breast cancer.NCT02040857·San Francisco, California and 9 others

CompletedMass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)The primary objective of this study, sponsored by Travera Inc. in Massachusetts, is to validate whether the mass response biomarker has potential to predict response of patients…NCT05461430·Oakland, California

TerminatedTargeted Intra-Operative Radiotherapy for the Management of Ductal Carcinoma In-Situ of the BreastWe hypothesize that the combination of mammography and CE-MRI will improve the surgeon and radiologist's ability to define extent of disease prior to surgical resection, improve…NCT00556907·Los Angeles, California

PreviousPage 63 of 93Next

Other Conditions in California

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma